18 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
CTMX CytomX Therapeutics, Inc. $18.52 $832.73M N/A
Article Searches
CytomX Therapeutics, Inc. (CTMX) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/13/cytomx-therapeutics-inc-ctmx-q1-2019-earnings-call.aspx?source=iedfolrf0000001 May 13, 2019 - CTMX earnings call for the period ending March 31, 2019.
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4262349-cytomx-therapeutics-inc-ctmx-ceo-sean-mccarthy-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 09, 2019 - CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2019 Earnings Conference Call May 09, 2019, 17:00 ET Company Participants Christopher Keenan - VP of IR & Corporate Communications Sean McCarthy - Chairm
CytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/412239/cytomx-therapeutics-ctmx-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-412239 May 09, 2019 - CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of 41.51% and 116.96%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CytomX Therapeutics (CTMX) to Report a Decline in Earnings: What to Look Out for http://www.zacks.com/stock/news/406679/analysts-estimate-cytomx-therapeutics-ctmx-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-406679 May 01, 2019 - CytomX Therapeutics (CTMX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CytomX Therapeutics' (CTMX) CEO Sean McCarthy on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4244999-cytomx-therapeutics-ctmx-ceo-sean-mccarthy-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare Feb 27, 2019 - CytomX Therapeutics (NASDAQ:CTMX) Q4 2018 Earnings Conference Call February 27, 2019, 5:00 pm ET Company Participants Chris Keenan - VP, IR Sean McCarthy - President, CEO & Chairman Debanjan Ray -
Analysts Estimate CytomX Therapeutics (CTMX) to Report a Decline in Earnings: What to Look Out for http://www.zacks.com/stock/news/355756/analysts-estimate-cytomx-therapeutics-ctmx-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-355756 Feb 20, 2019 - CytomX Therapeutics (CTMX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4221092-cytomx-therapeutics-inc-ctmx-ceo-sean-mccarthy-q3-2018-results-earnings-call-transcript?source=feed_sector_healthcare Nov 11, 2018 - Start Time: 17:00 End Time: 17:34 CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q3 2018 Earnings Conference Call November 06, 2018, 17:00 PM ET Executives Sean McCarthy - President and CEO Debanjan Ray - CF
CytomX Therapeutics (CTMX) Presents At Bank Of America Merrill Lynch 2018 Healthcare Conference - Slideshow https://seekingalpha.com/article/4175462-cytomx-therapeutics-ctmx-presents-bank-america-merrill-lynch-2018-healthcare-conference?source=feed_sector_healthcare May 18, 2018 - The following slide deck was published by CytomX Therapeutics in conjunction with this event.
CytomX Therapeutics' (CTMX) CEO Sean McCarthy on Q4 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4154316-cytomx-therapeutics-ctmx-ceo-sean-mccarthy-q4-2017-results-earnings-call-transcript?source=feed_sector_healthcare Mar 07, 2018 - CytomX Therapeutics (NASDAQ:CTMX) Q4 2017 Earnings Conference Call March 07, 2018 05:00 PM ET Executives Debanjan Ray - CFO Sean McCarthy - President & CEO Analysts Mohit Bansal - Citigroup Christ
Biotech Stock Roundup: Regeneron Down on Eylea Data, Biogen-Alkermes in MS Deal http://www.zacks.com/stock/news/284373/biotech-stock-roundup-regeneron-down-on-eylea-data-biogen-alkermes-in-ms-deal?cid=CS-ZC-FT-284373 Nov 29, 2017 - While there were not too many updates this week, companies like Regeneron (REGN) and Biogen were in the news related to their pipeline.

Pages: 12

Page 1